The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Proacta
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Clovis Oncology; Daiichi Sankyo; Genentech; Lilly; Merck; MSD; Novartis; Pfizer; Proacta; Takeda (Inst)
Research Funding - Boehringer Ingelheim (Inst)
Efficacy and safety of the ALK inhibitor alectinib in ALK+ non-small-cell lung cancer (NSCLC) patients who have failed prior crizotinib: an open-label, single-arm, global phase 2 study (NP28673).
 
Sai-Hong Ignatius Ou
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer; Proacta
Speakers' Bureau - Boehringer Ingelheim; Proacta
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Pfizer (Inst); Proacta (Inst)
 
Jin Seok Ahn
Honoraria - Astellas Pharma; AstraZeneca; Pfizer; Proacta
 
Luigi De Petris
No Relationships to Disclose
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Merck; Pfizer
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Merck
 
James Chih-Hsin Yang
No Relationships to Disclose
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - Proacta
Travel, Accommodations, Expenses - Proacta
 
Hervé Lena
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Proacta
Research Funding - Proacta (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Lilly; Pfizer; Proacta
 
Denis Moro-Sibilot
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Lilly/ImClone; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Lilly/ImClone; Pfizer; Roche/Genentech
 
Alessandra Bearz
No Relationships to Disclose
 
Santiago Viteri Ramirez
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - AstraZeneca; Pfizer
 
Tarek Mekhail
Honoraria - Celgene; Genentech; Lilly
Consulting or Advisory Role - Celgene; Genentech; Pfizer
Speakers' Bureau - Celgene; Genentech; Lilly; Novartis
Research Funding - Bristol-Myers Squibb; Celgene; Genentech; Lilly
 
Alexander I. Spira
Research Funding - Proacta
 
Ali Hassan Zeaiter
Employment - Proacta
Leadership - Proacta
Stock and Other Ownership Interests - Proacta
 
Walter Bordogna
Employment - Proacta
 
Bogdana Balas
Employment - Proacta; Proacta (I)
Stock and Other Ownership Interests - Proacta
 
Sophie Golding
Employment - Proacta; Proacta (I)
Stock and Other Ownership Interests - Proacta
 
Peter N. Morcos
Employment - Roche Pharma AG
Stock and Other Ownership Interests - Roche Pharma AG
 
Dong-Wan Kim
Consulting or Advisory Role - Novartis